Every year in Afghanistan, more than 60,000 citizens contract tuberculosis. A bacteria called mycobacterium tuberculosis causes the disease and spreads from one infected person to another through the air. Individuals recover from tuberculosis with antibiotics; however, some people struggle to recover with regular medicine. Multi-drug resistant tuberculosis (MDR-TB) occurs when individuals develop resistance to the antibiotics isoniazid and rifampicin. The United Nations Development Programme (UNDP), Medecins San Frontieres (MSF) and the Oriental Consultants Global Co., Ltd. (OC Global) work toward diagnosing, treating and improving tuberculosis in Afghanistan.
Medecins San Frontieres
MSF came to Afghanistan in 1980 and strives to serve individuals with critical medical conditions, children and pregnant women. More specifically, MSF started its MDR-TB program in 2017 to improve the quality of life of individuals with MDR-TB. Since the program’s inception, MSF identified over 40 patients with multi-drug resistant tuberculosis in Afghanistan and many of them received treatment that lasted nine months, as opposed to the standard 20 months. The short treatment time helped eliminate the negative symptoms the patients endured with regular treatment. During their treatment, MDR-TB patients received one of the two antibiotics called bedaquiline and delamanid.
Some patients reside at the association’s clinic in Kandahar to receive antibiotics every day. During their stay, individuals affected with MDR-TB consume nutritious food to help them recover faster. Also, the patients receive counseling and learn how to stop the transmission of tuberculosis to their loved ones.
United Nations Development Programme
The Government of Afghanistan provides universal healthcare to all its citizens. However, many Afghani citizens with MDR-TB do not receive treatment due to the inability to travel to medical centers in the city. The United Nations Development Programme (UNDP) noticed the struggle that individuals endured to get medical care and constructed four treatment centers in Kabul, Nangarhar, Herat and Balkh. The UNDP came to Afghanistan over half a century ago and strives to get rid of destitution, establish systemic change and teach citizens to be adaptable. More specifically, UNDP works towards providing better medical treatment for citizens affected with MDR-TB.
With the help of donations from the Global Fund, each treatment center bought over 20 beds and built enough space to manage 200 patients. Next, over 1,000 health care workers learned how to better identify and manage the disease. Lastly, programs teach Afghani citizens about the disease to decrease judgment towards MDR-TB patients.
Oriental Consultants Global Co., Ltd.
OC Global began helping Afghanistan in 2009 and aims to construct innovative projects all over the world. In Afghanistan, the corporation helped build a new hospital in Kabul that aims to reduce the number of MDR-TB cases.
Inside the hospital, a laboratory allows medical professionals to draw blood from patients to diagnose them more efficiently and swiftly. Next, the corporation bought all the necessary equipment needed to provide better medical treatment. Lastly, with the data collected from the patients, the hospital learns more about the disease and spreads this knowledge to others.
All in all, MSF, UNDP and OC Global assist in lowering the cases of multi-drug resistant tuberculosis in Afghanistan. These organizations strive to provide easy access to medical care, better quality treatment and a quick diagnosis. As more citizens become aware of the services provided by these three entities, complete management of MDR-TB appears achievable.
– Samantha Rodriguez-Silva